Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Oct;59(10):2351-3.
doi: 10.2337/db10-0912.

Targeting ceramide synthesis to reverse insulin resistance

Affiliations
Comment

Targeting ceramide synthesis to reverse insulin resistance

Carsten Schmitz-Peiffer. Diabetes. 2010 Oct.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Roles of SPT, CerS, and sphingomyelinase (SMase) in the metabolism of ceramides. De novo synthesis of ceramide is initiated by the condensation of serine with palmitoyl-CoA by SPT to generate the sphingoid backbone. A range of saturated and unsaturated fatty acids (acyl-CoA) can be subsequently incorporated by CerS (LASS) isoforms to form the ceramide sidechain. The salvage pathway, responsible for the cycling between ceramide and complex sphingolipids, also involves CerS activity and can also promote ceramide accumulation upon fatty acid oversupply. See references (9) and (24) for further details of sphingolipid metabolism. Inflammation can promote ceramide release from sphingomyelin through the activation of SMase by cytokines. Studies in intact cells and in vivo suggest that ceramide (and possibly also complex sphingolipids) can affect insulin action at least in part by inducing further stress signaling and mitochondrial dysfunction as well as by directly inhibiting insulin signal transduction.

Comment on

References

    1. Schmitz-Peiffer C, Biden TJ. Protein kinase C function in muscle, liver, and β-cells and its therapeutic implications for type 2 diabetes. Diabetes 2008;57:1774–1783 - PMC - PubMed
    1. Erion DM, Shulman GI. Diacylglycerol-mediated insulin resistance. Nat Med 2010;16:400–402 - PMC - PubMed
    1. Summers SA. Sphingolipids and insulin resistance: the five Ws. Curr Opin Lipidol 2010;21:128–135 - PubMed
    1. Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, Zabielski P, Adamska A, Blachnio A, Gorski J, Gorska M. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 2007;50:2366–2373 - PubMed
    1. Coen PM, Dubé JJ, Amati F, Stefanovic-Racic M, Ferrell RE, Toledo FG, Goodpaster BH. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 2010;59:80–88 - PMC - PubMed

MeSH terms